Your browser doesn't support javascript.
loading
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.
Hashemi, Mehrdad; Abbaszadeh, Sahar; Rashidi, Mohsen; Amini, Nafisesadat; Talebi Anaraki, Kasra; Motahhary, Motahhar; Khalilipouya, Ensi; Harif Nashtifani, Abdorrahman; Shafiei, Sasan; Ramezani Farani, Marzieh; Nabavi, Noushin; Salimimoghadam, Shokooh; Aref, Amir Reza; Raesi, Rasoul; Taheriazam, Afshin; Entezari, Maliheh; Zha, Wenliang.
Afiliación
  • Hashemi M; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Abbaszadeh S; Faculty of Medicine, Islamic Azad University Tonekabon Branch, Tonekabon, Iran.
  • Rashidi M; Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; The Health of Plant and Livestock Products Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Amini N; Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Talebi Anaraki K; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Motahhary M; General Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khalilipouya E; Department of Radiology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Harif Nashtifani A; Department of Health Care Management, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Shafiei S; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Ramezani Farani M; Department of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran.
  • Nabavi N; Department of Urologic Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, V6H3Z6, Canada.
  • Salimimoghadam S; Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Aref AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Xsphera Biosciences, Translational Medicine Group, 6 Tide Street, Boston, MA, 02210, USA.
  • Raesi R; Health Services Management, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical-Surgical Nursing, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Raesi.br881@gmail.com.
  • Taheriazam A; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Orthopedics, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: a.taheriazam@iautmu.ac.
  • Entezari M; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: men
  • Zha W; Second Affiliated Hospital, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China. Electronic address: xyzwl800@163.com.
Environ Res ; 233: 116458, 2023 09 15.
Article en En | MEDLINE | ID: mdl-37348629

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Environ Res Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Environ Res Año: 2023 Tipo del documento: Article País de afiliación: Irán